Cystatin C and Cardiovascular Disease Causality, Association, and Clinical Implications of Knowing the Difference

被引：9
作者：
Levin, Adeera [1 ]
Lan, James H. [2 ]
机构：
[1] Univ British Columbia, Div Nephrol, Vancouver, BC, Canada
[2] Univ British Columbia, Nephrol & Kidney Transplantat Unit, Vancouver, BC, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 09期
关键词：
coronary heart disease; genetics; heart failure; ischemic stroke; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; MENDELIAN RANDOMIZATION; BIOMARKERS; RISK; ATHEROSCLEROSIS; EVENTS; SOUL; EPIDEMIOLOGY; MORTALITY;
D O I：
10.1016/j.jacc.2016.06.037
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：946 / 948
页数：3
相关论文
共 22 条
[1]   Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice [J].
Bengtsson, E ;
To, F ;
Håkansson, K ;
Grubb, A ;
Brånén, L ;
Nilsson, J ;
Jovinge, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2151-2156
[2]   Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment [J].
Coll, E ;
Botey, A ;
Alvarez, L ;
Poch, E ;
Quintó, L ;
Saurina, A ;
Vera, M ;
Piera, C ;
Darnell, A .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) :29-34
[3]   Mendelian randomization as an instrumental variable approach to causal inference [J].
Didelez, Vanessa ;
Sheehan, Nuala .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2007, 16 (04) :309-330
[4]   Biomarkers in chronic kidney disease: a review [J].
Fassett, Robert G. ;
Venuthurupalli, Sree K. ;
Gobe, Glenda C. ;
Coombes, Jeff S. ;
Cooper, Matthew A. ;
Hoy, Wendy E. .
KIDNEY INTERNATIONAL, 2011, 80 (08) :806-821
[5]   Serum cystatin C concentration as a marker of renal dysfunction in the elderly [J].
Fliser, D ;
Ritz, E .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (01) :79-83
[6]   Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study [J].
Ix, Joachim H. ;
Shlipak, Michael G. ;
Chertow, Glenn M. ;
Whooley, Mary A. .
CIRCULATION, 2007, 115 (02) :173-179
[7]   Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study [J].
Keller, Till ;
Messow, Claudia Martina ;
Lubos, Edith ;
Nicaud, Viviane ;
Wild, Philipp S. ;
Rupprecht, Hans J. ;
Bickel, Christoph ;
Tzikas, Stergios ;
Peetz, Dirk ;
Lackner, Karl J. ;
Tiret, Laurence ;
Muenzel, Thomas ;
Blankenberg, Stefan ;
Schnabel, Renate B. .
EUROPEAN HEART JOURNAL, 2009, 30 (03) :314-320
[8]   Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement [J].
Knight, EL ;
Verhave, JC ;
Spiegelman, D ;
Hillege, HL ;
De Zeeuw, D ;
Curhan, GC ;
De Jong, PE .
KIDNEY INTERNATIONAL, 2004, 65 (04) :1416-1421
[9]   Impact of Elevated Cystatin C Level on Cardiovascular Disease Risk in Predominantly High Cardiovascular Risk Populations A Meta-Analysis [J].
Lee, Meng ;
Saver, Jeffrey L. ;
Huang, Wen-Hung ;
Chow, Jessica ;
Chang, Kuo-Hsuan ;
Ovbiagele, Bruce .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (06) :675-U189
[10]   Lysosomal cysteine proteases in atherosclerosis [J].
Liu, JA ;
Sukhova, GK ;
Sun, JS ;
Xu, WH ;
Libby, P ;
Shi, GP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1359-1366
123